A new study led by Loic Deleyrolle, Ph.D., an assistant professor of neurosurgery, has implications for advancing new metabolic therapies for glioblastoma, the deadliest form of brain cancer.
A new article examining data from clinical trials led by Melissa Armstrong, M.D., an assistant professor of neurology, shows that nusinersen treatment benefits certain patients with spinal muscular atrophy.
A new discovery led by Dr. Catherine Flores using stem cells to overcome resistance to immunotherapy drugs may open the door to more effective treatment for brain cancer.
The role of epigenetics in the process of brain aging and cognitive decline.
Melissa Armstrong, M.D., an assistant professor of neurology, partnered with the Lewy Body Dementia Association to survey the families of patients who had dementia with Lewy bodies.
In a recent editorial in JAMA Neurology, a group of neurologists at at The Fixel Center for Neurological Diseases at UF Health discuss medication trends for Parkinson's disease dementia.
Addiction research led by Drs. Caitlin Orsini and Marcelo Febo, was recently chosen as a Research Highlight in the journal eNeuro.
In The Conversation, Dr. Duane Mitchell discusses the importance of Drs. James Allison and Tasuku Honjo's discoveries in immunotherapy.
In The Conversation, Dr. Melissa Armstrong explains LBD, how it's diagnosed and current avenues for researching the disease.